Clinical trial Recruiting at 1 site Observational Ages 20 to 80

Investigating persistent villous atrophy in celiac disease patients on a strict gluten-free diet

Official title: Study of the Causes and Consequences of Persistent Villous Atrophy Despite an Intentionally Strict Gluten-free Diet in Celiac Disease Patients - Effect of an Ultra-strict Gluten-free Diet on Persistent Villous Atrophy

Run by Hospital Mutua de Terrassa · NCT06500754 · Data updated 2026-11-12

This study is trying to find out why some people with celiac disease still have gut problems even after sticking to a strict gluten-free diet for two years.

More Celiac Disease trials

Quick facts

Study typeObservational
Ages20 Years to 80 Years
SexAll
Enrollment80 (estimated)
SponsorHospital Mutua de Terrassa
Academic / other
Locations1 site (Terrassa, Barcelona)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedJanuary 1, 2026
Study endsJanuary 1, 2027
Registry record updatedJuly 19, 2024
Trial IDNCT06500754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with celiac disease who have been on a strict gluten-free diet for at least two years and show signs of persistent villous atrophy.

Probably not a fit

Patients with refractory celiac disease or other significant gastrointestinal disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on celiac disease patients who continue to experience villous atrophy despite adhering to a strict gluten-free diet for at least two years. It aims to identify the factors contributing to this persistent condition and its potential long-term complications. Participants will be monitored for their dietary adherence and serological responses, providing insights into the relationship between diet, microbiota, and epigenetics in celiac disease. The study seeks to enhance understanding of the clinical implications of ongoing villous atrophy in these patients.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for celiac disease patients who do not respond adequately to a gluten-free diet.

How similar studies have gone: While there have been studies on celiac disease and gluten-free diets, the specific focus on persistent villous atrophy in well-adhered patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age at diagnosis 18 years or more.
* Diagnosis of CD with villous atrophy, positive serology and clinical and serological response to GFD.
* To be in a GFD for at least 2 years, with good adherence to it.
* Negative or positive anti-transglutaminase (tTG2) IgA antibodies at low titers (\<2 times the normal value) at recruitment.
* Written informed consent.

Exclusion Criteria:

* Refractory CD (RCD) type 2 and type 1
* Other associated intestinal diseases (inflammatory bowel disease, microscopic colitis, other types of enteropathies).
* Need for treatment with corticosteroids or immunosuppressants.
* Surgeries or other diseases predisposing to bacterial overgrowth in the small intestine.
* Pregnancy, lactation.
* Associated chronic diseases (lung, heart, kidney, liver cirrhosis).
* Alcoholism or drug addiction.
* Schizophrenia-type psychiatric diseases, other psychoses, bipolar.

Where it's running

  • Hospital Universitari MútuaTerrassa
    Terrassa, Barcelona, Spain
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.